Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1950 3
1951 6
1952 2
1953 4
1954 5
1955 3
1956 3
1957 7
1958 1
1959 3
1960 4
1961 18
1962 16
1963 22
1964 25
1965 26
1966 33
1967 36
1968 29
1969 36
1970 46
1971 37
1972 44
1973 41
1974 48
1975 77
1976 62
1977 73
1978 96
1979 92
1980 87
1981 107
1982 109
1983 139
1984 128
1985 168
1986 180
1987 175
1988 209
1989 198
1990 214
1991 209
1992 211
1993 238
1994 240
1995 286
1996 285
1997 278
1998 348
1999 315
2000 358
2001 351
2002 309
2003 331
2004 419
2005 390
2006 392
2007 406
2008 445
2009 481
2010 490
2011 538
2012 571
2013 585
2014 583
2015 605
2016 639
2017 705
2018 677
2019 671
2020 742
2021 787
2022 804
2023 640
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

16,489 results

Results by year

Filters applied: . Clear all
Page 1
Helicobacter pylori, Homologous-Recombination Genes, and Gastric Cancer.
Usui Y, Taniyama Y, Endo M, Koyanagi YN, Kasugai Y, Oze I, Ito H, Imoto I, Tanaka T, Tajika M, Niwa Y, Iwasaki Y, Aoi T, Hakozaki N, Takata S, Suzuki K, Terao C, Hatakeyama M, Hirata M, Sugano K, Yoshida T, Kamatani Y, Nakagawa H, Matsuda K, Murakami Y, Spurdle AB, Matsuo K, Momozawa Y. Usui Y, et al. Among authors: tanaka t. N Engl J Med. 2023 Mar 30;388(13):1181-1190. doi: 10.1056/NEJMoa2211807. N Engl J Med. 2023. PMID: 36988593
Direct pulp capping procedures - Evidence and practice.
Islam R, Islam MRR, Tanaka T, Alam MK, Ahmed HMA, Sano H. Islam R, et al. Among authors: tanaka t. Jpn Dent Sci Rev. 2023 Dec;59:48-61. doi: 10.1016/j.jdsr.2023.02.002. Epub 2023 Feb 26. Jpn Dent Sci Rev. 2023. PMID: 36880059 Free PMC article. Review.
Cryo-EM structure of the transposon-associated TnpB enzyme.
Nakagawa R, Hirano H, Omura SN, Nety S, Kannan S, Altae-Tran H, Yao X, Sakaguchi Y, Ohira T, Wu WY, Nakayama H, Shuto Y, Tanaka T, Sano FK, Kusakizako T, Kise Y, Itoh Y, Dohmae N, van der Oost J, Suzuki T, Zhang F, Nureki O. Nakagawa R, et al. Among authors: tanaka t. Nature. 2023 Apr;616(7956):390-397. doi: 10.1038/s41586-023-05933-9. Epub 2023 Apr 5. Nature. 2023. PMID: 37020030 Free PMC article.
Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study.
Sallman DA, Al Malki MM, Asch AS, Wang ES, Jurcic JG, Bradley TJ, Flinn IW, Pollyea DA, Kambhampati S, Tanaka TN, Zeidner JF, Garcia-Manero G, Jeyakumar D, Komrokji R, Lancet J, Kantarjian HM, Gu L, Zhang Y, Tan A, Chao M, O'Hear C, Ramsingh G, Lal I, Vyas P, Daver NG. Sallman DA, et al. Among authors: tanaka tn. J Clin Oncol. 2023 May 20;41(15):2815-2826. doi: 10.1200/JCO.22.01794. Epub 2023 Mar 8. J Clin Oncol. 2023. PMID: 36888930 Clinical Trial.
Medium-chain fatty acids suppress lipotoxicity-induced hepatic fibrosis via the immunomodulating receptor GPR84.
Ohue-Kitano R, Nonaka H, Nishida A, Masujima Y, Takahashi D, Ikeda T, Uwamizu A, Tanaka M, Kohjima M, Igarashi M, Katoh H, Tanaka T, Inoue A, Suganami T, Hase K, Ogawa Y, Aoki J, Kimura I. Ohue-Kitano R, et al. Among authors: tanaka t. JCI Insight. 2023 Jan 24;8(2):e165469. doi: 10.1172/jci.insight.165469. JCI Insight. 2023. PMID: 36480287 Free PMC article.
Lithium-Mediated Mechanochemical Cyclodehydrogenation.
Fujishiro K, Morinaka Y, Ono Y, Tanaka T, Scott LT, Ito H, Itami K. Fujishiro K, et al. Among authors: tanaka t. J Am Chem Soc. 2023 Apr 12;145(14):8163-8175. doi: 10.1021/jacs.3c01185. Epub 2023 Apr 3. J Am Chem Soc. 2023. PMID: 37011146
A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid Malignancies.
Lachowiez CA, Loghavi S, Zeng Z, Tanaka T, Kim YJ, Uryu H, Turkalj S, Jakobsen NA, Luskin MR, Duose DY, Tidwell RSS, Short NJ, Borthakur G, Kadia TM, Masarova L, Tippett GD, Bose P, Jabbour EJ, Ravandi F, Daver NG, Garcia-Manero G, Kantarjian H, Garcia JS, Vyas P, Takahashi K, Konopleva M, DiNardo CD. Lachowiez CA, et al. Among authors: tanaka t. Blood Cancer Discov. 2023 Jul 5;4(4):276-293. doi: 10.1158/2643-3230.BCD-22-0205. Blood Cancer Discov. 2023. PMID: 37102976 Clinical Trial.
16,489 results
You have reached the last available page of results. Please see the User Guide for more information.